 | • レポートコード：D0GIR-02168 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥508,080 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥762,120 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,016,160 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、乳癌リキッドバイオプシーの世界市場を広く調査・分析し、今後の市場展望をまとめております。乳癌リキッドバイオプシーの種類別市場規模（循環腫瘍細胞（CTC）、無細胞DNA（CfDNA）、細胞外小胞（EV）、その他循環バイオマーカー）、用途別市場規模（病院、診断センター、研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：QIAGEN、Illumina、Myriad Genetics、Roche Diagnostics、Thermo Fisher Scientific、Bio-Rad Laboratories、Trovagene、Genomic Health、Menarini Silicon Biosystems、Biocept、Guardant Health、RainDance Technologies、MDx Health ・地域別グローバル市場分析 2015年-2020年 ・乳癌リキッドバイオプシーの北米市場（アメリカ、カナダ、メキシコ） ・乳癌リキッドバイオプシーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・乳癌リキッドバイオプシーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・乳癌リキッドバイオプシーの南米市場（ブラジル、アルゼンチン） ・乳癌リキッドバイオプシーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：循環腫瘍細胞（CTC）、無細胞DNA（CfDNA）、細胞外小胞（EV）、その他循環バイオマーカー ・用途別分析：病院、診断センター、研究所 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Breast Cancer Liquid Biopsy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Breast Cancer Liquid Biopsy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Breast Cancer Liquid Biopsy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Breast Cancer Liquid Biopsy market has been segmented into:
Circulating Tumor Cells (CTCs)
Cell-Free DNA (CfDNA)
Extracellular Vesicles (EVs)
Other Circulating Biomarkers
By Application, Breast Cancer Liquid Biopsy has been segmented into:
Hospitals
Diagnostic Centers
Laboratories
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Breast Cancer Liquid Biopsy market presented in the report. This section sheds light on the sales growth of different regional and country-level Breast Cancer Liquid Biopsy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Breast Cancer Liquid Biopsy market.
The report offers in-depth assessment of the growth and other aspects of the Breast Cancer Liquid Biopsy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Breast Cancer Liquid Biopsy Market Share Analysis
Breast Cancer Liquid Biopsy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Breast Cancer Liquid Biopsy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Breast Cancer Liquid Biopsy sales, revenue and market share for each player covered in this report.
The major players covered in Breast Cancer Liquid Biopsy are:
QIAGEN
Illumina
Myriad Genetics
Roche Diagnostics
Thermo Fisher Scientific
Bio-Rad Laboratories
Trovagene
Genomic Health
Menarini Silicon Biosystems
Biocept
Guardant Health
RainDance Technologies
MDx Health
Table of Contents
1 Breast Cancer Liquid Biopsy Market Overview
1.1 Product Overview and Scope of Breast Cancer Liquid Biopsy
1.2 Classification of Breast Cancer Liquid Biopsy by Type
1.2.1 Global Breast Cancer Liquid Biopsy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Type in 2019
1.2.3 Circulating Tumor Cells (CTCs)
1.2.4 Cell-Free DNA (CfDNA)
1.2.5 Extracellular Vesicles (EVs)
1.2.6 Other Circulating Biomarkers
1.3 Global Breast Cancer Liquid Biopsy Market by Application
1.3.1 Overview: Global Breast Cancer Liquid Biopsy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Laboratories
1.4 Global Breast Cancer Liquid Biopsy Market by Regions
1.4.1 Global Breast Cancer Liquid Biopsy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Breast Cancer Liquid Biopsy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Breast Cancer Liquid Biopsy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Breast Cancer Liquid Biopsy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Breast Cancer Liquid Biopsy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Breast Cancer Liquid Biopsy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Breast Cancer Liquid Biopsy Status and Prospect (2015-2025)
2 Company Profiles
2.1 QIAGEN
2.1.1 QIAGEN Details
2.1.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 QIAGEN SWOT Analysis
2.1.4 QIAGEN Product and Services
2.1.5 QIAGEN Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Illumina SWOT Analysis
2.2.4 Illumina Product and Services
2.2.5 Illumina Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Myriad Genetics
2.3.1 Myriad Genetics Details
2.3.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Myriad Genetics SWOT Analysis
2.3.4 Myriad Genetics Product and Services
2.3.5 Myriad Genetics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche Diagnostics
2.4.1 Roche Diagnostics Details
2.4.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche Diagnostics SWOT Analysis
2.4.4 Roche Diagnostics Product and Services
2.4.5 Roche Diagnostics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Thermo Fisher Scientific SWOT Analysis
2.5.4 Thermo Fisher Scientific Product and Services
2.5.5 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bio-Rad Laboratories SWOT Analysis
2.6.4 Bio-Rad Laboratories Product and Services
2.6.5 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Trovagene
2.7.1 Trovagene Details
2.7.2 Trovagene Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Trovagene SWOT Analysis
2.7.4 Trovagene Product and Services
2.7.5 Trovagene Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genomic Health
2.8.1 Genomic Health Details
2.8.2 Genomic Health Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genomic Health SWOT Analysis
2.8.4 Genomic Health Product and Services
2.8.5 Genomic Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Menarini Silicon Biosystems
2.9.1 Menarini Silicon Biosystems Details
2.9.2 Menarini Silicon Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Menarini Silicon Biosystems SWOT Analysis
2.9.4 Menarini Silicon Biosystems Product and Services
2.9.5 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Biocept
2.10.1 Biocept Details
2.10.2 Biocept Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Biocept SWOT Analysis
2.10.4 Biocept Product and Services
2.10.5 Biocept Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Guardant Health
2.11.1 Guardant Health Details
2.11.2 Guardant Health Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Guardant Health SWOT Analysis
2.11.4 Guardant Health Product and Services
2.11.5 Guardant Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.12 RainDance Technologies
2.12.1 RainDance Technologies Details
2.12.2 RainDance Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 RainDance Technologies SWOT Analysis
2.12.4 RainDance Technologies Product and Services
2.12.5 RainDance Technologies Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
2.13 MDx Health
2.13.1 MDx Health Details
2.13.2 MDx Health Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 MDx Health SWOT Analysis
2.13.4 MDx Health Product and Services
2.13.5 MDx Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Breast Cancer Liquid Biopsy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Breast Cancer Liquid Biopsy Players Market Share
3.2.2 Top 10 Breast Cancer Liquid Biopsy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Breast Cancer Liquid Biopsy Revenue and Market Share by Regions
4.2 North America Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
4.3 Europe Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
4.5 South America Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
5 North America Breast Cancer Liquid Biopsy Revenue by Countries
5.1 North America Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
5.2 USA Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
5.3 Canada Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
5.4 Mexico Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
6 Europe Breast Cancer Liquid Biopsy Revenue by Countries
6.1 Europe Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
6.2 Germany Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
6.3 UK Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
6.4 France Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
6.5 Russia Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
6.6 Italy Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Countries
7.1 Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
7.2 China Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
7.3 Japan Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
7.4 Korea Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
7.5 India Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
8 South America Breast Cancer Liquid Biopsy Revenue by Countries
8.1 South America Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
8.2 Brazil Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
8.3 Argentina Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Breast Cancer Liquid Biopsy by Countries
9.1 Middle East & Africa Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
9.3 UAE Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
9.4 Egypt Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
9.5 South Africa Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Breast Cancer Liquid Biopsy Revenue and Market Share by Type (2015-2020)
10.2 Global Breast Cancer Liquid Biopsy Market Forecast by Type (2019-2024)
10.3 Circulating Tumor Cells (CTCs) Revenue Growth Rate (2015-2025)
10.4 Cell-Free DNA (CfDNA) Revenue Growth Rate (2015-2025)
10.5 Extracellular Vesicles (EVs) Revenue Growth Rate (2015-2025)
10.6 Other Circulating Biomarkers Revenue Growth Rate (2015-2025)
11 Global Breast Cancer Liquid Biopsy Market Segment by Application
11.1 Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2015-2020)
11.2 Breast Cancer Liquid Biopsy Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Diagnostic Centers Revenue Growth (2015-2020)
11.5 Laboratories Revenue Growth (2015-2020)
12 Global Breast Cancer Liquid Biopsy Market Size Forecast (2021-2025)
12.1 Global Breast Cancer Liquid Biopsy Market Size Forecast (2021-2025)
12.2 Global Breast Cancer Liquid Biopsy Market Forecast by Regions (2021-2025)
12.3 North America Breast Cancer Liquid Biopsy Revenue Market Forecast (2021-2025)
12.4 Europe Breast Cancer Liquid Biopsy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Breast Cancer Liquid Biopsy Revenue Market Forecast (2021-2025)
12.6 South America Breast Cancer Liquid Biopsy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Breast Cancer Liquid Biopsy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Breast Cancer Liquid Biopsy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Breast Cancer Liquid Biopsy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Breast Cancer Liquid Biopsy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Breast Cancer Liquid Biopsy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. QIAGEN Corporate Information, Location and Competitors
Table 6. QIAGEN Breast Cancer Liquid Biopsy Major Business
Table 7. QIAGEN Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 8. QIAGEN SWOT Analysis
Table 9. QIAGEN Breast Cancer Liquid Biopsy Product and Solutions
Table 10. QIAGEN Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Illumina Corporate Information, Location and Competitors
Table 12. Illumina Breast Cancer Liquid Biopsy Major Business
Table 13. Illumina Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2018-2019)
Table 14. Illumina SWOT Analysis
Table 15. Illumina Breast Cancer Liquid Biopsy Product and Solutions
Table 16. Illumina Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Myriad Genetics Corporate Information, Location and Competitors
Table 18. Myriad Genetics Breast Cancer Liquid Biopsy Major Business
Table 19. Myriad Genetics Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 20. Myriad Genetics SWOT Analysis
Table 21. Myriad Genetics Breast Cancer Liquid Biopsy Product and Solutions
Table 22. Myriad Genetics Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Diagnostics Corporate Information, Location and Competitors
Table 24. Roche Diagnostics Breast Cancer Liquid Biopsy Major Business
Table 25. Roche Diagnostics Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 26. Roche Diagnostics SWOT Analysis
Table 27. Roche Diagnostics Breast Cancer Liquid Biopsy Product and Solutions
Table 28. Roche Diagnostics Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 30. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Major Business
Table 31. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 32. Thermo Fisher Scientific SWOT Analysis
Table 33. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product and Solutions
Table 34. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 36. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Major Business
Table 37. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 38. Bio-Rad Laboratories SWOT Analysis
Table 39. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product and Solutions
Table 40. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Trovagene Corporate Information, Location and Competitors
Table 42. Trovagene Breast Cancer Liquid Biopsy Major Business
Table 43. Trovagene Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 44. Trovagene SWOT Analysis
Table 45. Trovagene Breast Cancer Liquid Biopsy Product and Solutions
Table 46. Trovagene Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Genomic Health Corporate Information, Location and Competitors
Table 48. Genomic Health Breast Cancer Liquid Biopsy Major Business
Table 49. Genomic Health Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 50. Genomic Health SWOT Analysis
Table 51. Genomic Health Breast Cancer Liquid Biopsy Product and Solutions
Table 52. Genomic Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Menarini Silicon Biosystems Corporate Information, Location and Competitors
Table 54. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Major Business
Table 55. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 56. Menarini Silicon Biosystems SWOT Analysis
Table 57. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product and Solutions
Table 58. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Biocept Corporate Information, Location and Competitors
Table 60. Biocept Breast Cancer Liquid Biopsy Major Business
Table 61. Biocept Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 62. Biocept SWOT Analysis
Table 63. Biocept Breast Cancer Liquid Biopsy Product and Solutions
Table 64. Biocept Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Guardant Health Corporate Information, Location and Competitors
Table 66. Guardant Health Breast Cancer Liquid Biopsy Major Business
Table 67. Guardant Health Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 68. Guardant Health SWOT Analysis
Table 69. Guardant Health Breast Cancer Liquid Biopsy Product and Solutions
Table 70. Guardant Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. RainDance Technologies Corporate Information, Location and Competitors
Table 72. RainDance Technologies Breast Cancer Liquid Biopsy Major Business
Table 73. RainDance Technologies Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 74. RainDance Technologies SWOT Analysis
Table 75. RainDance Technologies Breast Cancer Liquid Biopsy Product and Solutions
Table 76. RainDance Technologies Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. MDx Health Corporate Information, Location and Competitors
Table 78. MDx Health Breast Cancer Liquid Biopsy Major Business
Table 79. MDx Health Breast Cancer Liquid Biopsy Total Revenue (USD Million) (2017-2018)
Table 80. MDx Health SWOT Analysis
Table 81. MDx Health Breast Cancer Liquid Biopsy Product and Solutions
Table 82. MDx Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Breast Cancer Liquid Biopsy Revenue (Million USD) by Players (2015-2020)
Table 84. Global Breast Cancer Liquid Biopsy Revenue Share by Players (2015-2020)
Table 85. Global Breast Cancer Liquid Biopsy Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Breast Cancer Liquid Biopsy Revenue Market Share by Regions (2015-2020)
Table 87. North America Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
Table 88. North America Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)
Table 89. Europe Breast Cancer Liquid Biopsy Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Breast Cancer Liquid Biopsy Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
Table 92. South America Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Breast Cancer Liquid Biopsy Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)
Table 95. Global Breast Cancer Liquid Biopsy Revenue (Million USD) by Type (2015-2020)
Table 96. Global Breast Cancer Liquid Biopsy Revenue Share by Type (2015-2020)
Table 97. Global Breast Cancer Liquid Biopsy Revenue Forecast by Type (2021-2025)
Table 98. Global Breast Cancer Liquid Biopsy Revenue by Application (2015-2020)
Table 99. Global Breast Cancer Liquid Biopsy Revenue Share by Application (2015-2020)
Table 100. Global Breast Cancer Liquid Biopsy Revenue Forecast by Application (2021-2025)
Table 101. Global Breast Cancer Liquid Biopsy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Breast Cancer Liquid Biopsy Picture
Figure 2. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type in 2019
Figure 3. Circulating Tumor Cells (CTCs) Picture
Figure 4. Cell-Free DNA (CfDNA) Picture
Figure 5. Extracellular Vesicles (EVs) Picture
Figure 6. Other Circulating Biomarkers Picture
Figure 7. Breast Cancer Liquid Biopsy Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Diagnostic Centers Picture
Figure 10. Laboratories Picture
Figure 11. Global Breast Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Breast Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Breast Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Breast Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Breast Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Breast Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Breast Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Breast Cancer Liquid Biopsy Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Breast Cancer Liquid Biopsy Revenue Market Share in 2019
Figure 20. Global Top 10 Players Breast Cancer Liquid Biopsy Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Breast Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Breast Cancer Liquid Biopsy Revenue Market Share by Regions (2015-2020)
Figure 24. Global Breast Cancer Liquid Biopsy Revenue Market Share by Regions in 2018
Figure 25. North America Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 26. Europe Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 28. South America Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 30. North America Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)
Figure 31. North America Breast Cancer Liquid Biopsy Revenue Market Share by Countries in 2019
Figure 32. USA Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 33. Canada Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 35. Europe Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Breast Cancer Liquid Biopsy Revenue Market Share by Countries in 2019
Figure 37. Germany Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 38. UK Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 39. France Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 40. Russia Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 41. Italy Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Breast Cancer Liquid Biopsy Revenue Market Share by Countries in 2019
Figure 44. China Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 45. Japan Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 46. Korea Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 47. India Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 49. South America Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)
Figure 50. South America Breast Cancer Liquid Biopsy Revenue Market Share by Countries in 2019
Figure 51. Brazil Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Breast Cancer Liquid Biopsy Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 56. UAE Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Breast Cancer Liquid Biopsy Revenue and Growth Rate (2015-2020)
Figure 59. Global Breast Cancer Liquid Biopsy Revenue Share by Type (2015-2020)
Figure 60. Global Breast Cancer Liquid Biopsy Revenue Share by Type in 2019
Figure 61. Global Breast Cancer Liquid Biopsy Market Share Forecast by Type (2021-2025)
Figure 62. Global Circulating Tumor Cells (CTCs) Revenue Growth Rate (2015-2020)
Figure 63. Global Cell-Free DNA (CfDNA) Revenue Growth Rate (2015-2020)
Figure 64. Global Extracellular Vesicles (EVs) Revenue Growth Rate (2015-2020)
Figure 65. Global Other Circulating Biomarkers Revenue Growth Rate (2015-2020)
Figure 66. Global Breast Cancer Liquid Biopsy Revenue Share by Application (2015-2020)
Figure 67. Global Breast Cancer Liquid Biopsy Revenue Share by Application in 2019
Figure 68. Global Breast Cancer Liquid Biopsy Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 71. Global Laboratories Revenue Growth Rate (2015-2020)
Figure 72. Global Breast Cancer Liquid Biopsy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Breast Cancer Liquid Biopsy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Breast Cancer Liquid Biopsy Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Breast Cancer Liquid Biopsy Revenue Market Forecast (2021-2025)
Figure 76. Europe Breast Cancer Liquid Biopsy Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Breast Cancer Liquid Biopsy Revenue Market Forecast (2021-2025)
Figure 78. South America Breast Cancer Liquid Biopsy Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Breast Cancer Liquid Biopsy Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
乳癌イメージングの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Breast Cancer Imaging market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breast Cancer Imaging m…- HR+/HER2-乳がんの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The HR+/HER2- Breast Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 胸膜生検の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Pleural Biopsy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pleural Biopsy market report p…
- 循環腫瘍細胞（CTC）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Circulating Tumor Cell market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.5% in the forecast period of 2020 to 2025 and will expected to reach USD 9859 million by 2025, from USD 6382.4 million in 2019. The Circulating Tu…
- がん幹細胞の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Stem Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1366.2 million by 2025, from USD 883.8 million in 2019. The Cancer Stem Cells …